Corrigendum: Tumor-Associated Macrophages in Tumor Immunity

Yueyun Pan,Yinda Yu,Xiaojian Wang,Ting Zhang

DOI: https://doi.org/10.3389/fimmu.2021.775758

IF: 7.3

2021-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2020.583084.].

What problem does this paper attempt to address?

Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth

Ru Zhou,Mahboubeh Yazdanifar,Lopamudra Das Roy,Lynsey M. Whilding,Artemis Gavrill,John Maher,Pinku Mukherjee

DOI: https://doi.org/10.3389/fimmu.2020.628776

IF: 7.3

2020-12-07

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2019.01149.].

immunology
Corrigendum: Lipid metabolism and tumor immunotherapy

Yue Wang,Zongjin Guo,Adamu Danbala Isah,Shuangwei Chen,Yongfei Ren,Huazhong Cai

DOI: https://doi.org/10.3389/fcell.2024.1349379

IF: 5.5

2024-01-26

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2023.1187989.].

cell biology,developmental biology
Corrigendum: T lymphocyte cell: A pivotal player in lung cancer

Yanan Wu,Meng Yuan,Chenlin Wang,Yanfei Chen,Yan Zhang,Jiandong Zhang

DOI: https://doi.org/10.3389/fimmu.2023.1166352

IF: 7.3

2023-02-21

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1102778.].

immunology
Tumor-Associated Macrophages in Tumor Immunity (vol 11, 583084, 2020)

Yueyun Pan,Yinda Yu,Xiaojian Wang,Ting Zhang

DOI: https://doi.org/10.3389/fimmu.2021.775758

IF: 7.3

2021-01-01

Frontiers in Immunology

Abstract:Tumor-associated macrophages (TAMs) represent one of the main tumor-infiltrating immune cell types and are generally categorized into either of two functionally contrasting subtypes, namely classical activated M1 macrophages and alternatively activated M2 macrophages. The former typically exerts anti-tumor functions, including directly mediate cytotoxicity and antibody-dependent cell-mediated cytotoxicity (ADCC) to kill tumor cells; the latter can promote the occurrence and metastasis of tumor cells, inhibit T cell-mediated anti-tumor immune response, promote tumor angiogenesis, and lead to tumor progression. Both M1 and M2 macrophages have high degree of plasticity and thus can be converted into each other upon tumor microenvironment changes or therapeutic interventions. As the relationship between TAMs and malignant tumors becoming clearer, TAMs have become a promising target for developing new cancer treatment. In this review, we summarize the origin and types of TAMs, TAMs interaction with tumors and tumor microenvironment, and up-to-date treatment strategies targeting TAMs.
Corrigendum: Antigen Presentation Machinery Signature-Derived CALR Mediates Migration, Polarization of Macrophages in Glioma and Predicts Immunotherapy Response

Rui Chen,Hao Zhang,Wantao Wu,Shuyu Li,Zeyu Wang,Ziyu Dai,Zaoqu Liu,Jian Zhang,Peng Luo,Zhiwei Xia,Quan Cheng

DOI: https://doi.org/10.3389/fimmu.2022.931433

IF: 7.3

2022-06-02

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.833792.].

immunology
Corrigendum: Microbiome Crosstalk in Immunotherapy and Anti-Angiogenesis Therapy

Xueting Wan,Mengyao Song,Aiyun Wang,Yang Zhao,Zhonghong Wei,Yin Lu

DOI: https://doi.org/10.3389/fimmu.2022.887775

IF: 7.3

2022-04-21

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.747914.].

immunology
Corrigendum to “remodeling Tumor Immunosuppressive Microenvironment Via a Novel Bioactive Nanovaccines Potentiates the Efficacy of Cancer Immunotherapy” [bioactive Mater. 16 107–119]

Xiaoxue Xie,Yi Feng,Hanxi Zhang,Qingqing Su,Ting Song,Geng Yang,Ningxi Li,Xiaodan Wei,Tingting Li,Xiang Qin,Shun Li,Chunhui Wu,Xiaojuan Zhang,Guixue Wang,Yiyao Liu,Hong Yang

DOI: https://doi.org/10.1016/j.bioactmat.2022.09.001

IF: 18.9

2023-01-01

Bioactive Materials

Abstract:[This corrects the article DOI: 10.1016/j.bioactmat.2022.03.008.].
Erratum: New insights into the role of macrophages in cancer immunotherapy

Frontiers Production Office

DOI: https://doi.org/10.3389/fimmu.2024.1427337

IF: 7.3

2024-05-17

Frontiers in Immunology

Abstract:This article is an erratum on: New insights into the role of macrophages in cancer immunotherapy

immunology
Corrigendum: Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic Potential

Ya-Nan Pi,Wen-Cai Qi,Bai-Rong Xia,Ge Lou,Wei-Lin Jin

DOI: https://doi.org/10.3389/fimmu.2022.891942

IF: 7.3

2022-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.697083.].
Corrigendum: Multifunctions of CRIF1 in Cancers and Mitochondrial Dysfunction.

Yangzhou Jiang,Yang Xiang,Chuanchuan Lin,Weiwei Zhang,Zhenxing Yang,Lixin Xiang,Yanni Xiao,Li Chen,Qian Ran,Zhongjun Li

DOI: https://doi.org/10.3389/fonc.2023.1271492

IF: 4.7

2023-01-01

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.1009948.].
Corrigendum: Lipid metabolism in tumor immunology and immunotherapy

Lisa K. Duong,Halil Ibrahim Corbali,Thomas S. Riad,Shonik Ganjoo,Selene Nanez,Tiffany Voss,Hampartsoum B. Barsoumian,James Welsh,Maria Angelica Cortez

DOI: https://doi.org/10.3389/fonc.2023.1358498

IF: 4.7

2024-01-08

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2023.1187279.].

oncology
Corrigendum: Immunogenomic landscape in breast cancer reveals immunotherapeutically relevant gene signatures

Tao Wang,Tianye Li,Baiqing Li,Jiahui Zhao,Zhi Li,Mingyi Sun,Yan Li,Yanjiao Zhao,Shidi Zhao,Weiguang He,Xiao Guo,Rongjing Ge,Lian Wang,Dushan Ding,Saisai Liu,Simin Min,Xiaonan Zhang

DOI: https://doi.org/10.3389/fimmu.2023.1134847

IF: 7.3

2023-01-20

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.805184.].

immunology
Corrigendum: Innate Immune Cells in the Esophageal Tumor Microenvironment

Kele Cui,Shouxin Hu,Xinyu Mei,Min Cheng

DOI: https://doi.org/10.3389/fimmu.2021.708705

IF: 7.3

2021-01-01

Frontiers in Immunology

Abstract:CORRECTION article Front. Immunol., 27 May 2021Sec. Molecular Innate Immunity Volume 12 - 2021 | https://doi.org/10.3389/fimmu.2021.708705
Corrigendum: Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes

Thomas Morgan Hulen,Christina Friese,Nikolaj Pagh Kristensen,Joachim Stoltenborg Granhøj,Troels Holz Borch,Marlies J W Peeters,Marco Donia,Mads Hald Andersen,Sine Reker Hadrup,Inge Marie Svane,Özcan Met

DOI: https://doi.org/10.3389/fimmu.2024.1462081

2024-07-18

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1180997.].
Corrigendum: Thymic Epithelial Cells Contribute to Thymopoiesis and T Cell Development

Hong-Xia Wang,Wenrong Pan,Lei Zheng,Xiao-Ping Zhong,Liang Tan,Zhanfeng Liang,Jing He,Pingfeng Feng,Yong Zhao,Yu-Rong Qiu

DOI: https://doi.org/10.3389/fimmu.2020.628464

IF: 7.3

2020-11-30

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2019.03099.].

immunology
Corrigendum: Macrophage Polarization: Different Gene Signatures in M1(LPS+) vs. Classically and M2(LPS–) vs. Alternatively Activated Macrophages

Marco Orecchioni,Yanal Ghosheh,Akula Bala Pramod,Klaus Ley

DOI: https://doi.org/10.3389/fimmu.2020.00234

IF: 7.3

2020-02-25

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2019.01084.].

immunology
Corrigendum: Immune and Clinical Features of CD96 Expression in Glioma by in silico Analysis

Qiang Zhang,Hua Zhong,Yinchun Fan,Qian Liu,Jiancheng Song,Shengtao Yao,Fang Cao

DOI: https://doi.org/10.3389/fbioe.2020.599544

IF: 5.7

2020-10-23

Frontiers in Bioengineering and Biotechnology

Abstract:[This corrects the article DOI: 10.3389/fbioe.2020.00592.].

multidisciplinary sciences
Corrigendum: Identification and validation of immune-related methylation clusters for predicting immune activity and prognosis in breast cancer

Anli Yang,Ying Zhou,Yanan Kong,Xiaoli Wei,Feng Ye,Lijuan Zhang,Xian Zhong,Mingyue Li,Shilin Lu,Xin An,Weikai Xiao

DOI: https://doi.org/10.3389/fimmu.2024.1372991

IF: 7.3

2024-01-31

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.704557.].

immunology
Corrigendum: Chronic Stress: Impacts on Tumor Microenvironment and Implications for Anti-Cancer Treatments

Wentao Tian,Yi Liu,Chenghui Cao,Yue Zeng,Yue Pan,Xiaohan Liu,Yurong Peng,Fang Wu

DOI: https://doi.org/10.3389/fcell.2022.865043

IF: 5.5

2022-03-04

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2021.777018.].

cell biology,developmental biology
Corrigendum: Targeting Myc Interacting Proteins As a Winding Path in Cancer Therapy

Yihui Zhou,Xiaomeng Gao,Yuan Meng,Bo Yang,Qiaojun He,Ji Cao

DOI: https://doi.org/10.3389/fphar.2021.785732

IF: 5.6

2021-01-01

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.748852.].

Corrigendum: Tumor-Associated Macrophages in Tumor Immunity

Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth

Corrigendum: Lipid metabolism and tumor immunotherapy

Corrigendum: T lymphocyte cell: A pivotal player in lung cancer

Tumor-Associated Macrophages in Tumor Immunity (vol <i>11</i>, <i>583084</i>, <i>2020</i>)

Corrigendum: Antigen Presentation Machinery Signature-Derived CALR Mediates Migration, Polarization of Macrophages in Glioma and Predicts Immunotherapy Response

Corrigendum: Microbiome Crosstalk in Immunotherapy and Anti-Angiogenesis Therapy

Corrigendum to “remodeling Tumor Immunosuppressive Microenvironment Via a Novel Bioactive Nanovaccines Potentiates the Efficacy of Cancer Immunotherapy” [bioactive Mater. 16 107–119]

Erratum: New insights into the role of macrophages in cancer immunotherapy

Corrigendum: Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic Potential

Corrigendum: Multifunctions of CRIF1 in Cancers and Mitochondrial Dysfunction.

Corrigendum: Lipid metabolism in tumor immunology and immunotherapy

Corrigendum: Immunogenomic landscape in breast cancer reveals immunotherapeutically relevant gene signatures

Corrigendum: Innate Immune Cells in the Esophageal Tumor Microenvironment

Corrigendum: Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes

Corrigendum: Thymic Epithelial Cells Contribute to Thymopoiesis and T Cell Development

Corrigendum: Macrophage Polarization: Different Gene Signatures in M1(LPS+) vs. Classically and M2(LPS–) vs. Alternatively Activated Macrophages

Corrigendum: Immune and Clinical Features of CD96 Expression in Glioma by in silico Analysis

Corrigendum: Identification and validation of immune-related methylation clusters for predicting immune activity and prognosis in breast cancer

Corrigendum: Chronic Stress: Impacts on Tumor Microenvironment and Implications for Anti-Cancer Treatments

Corrigendum: Targeting Myc Interacting Proteins As a Winding Path in Cancer Therapy